Literature DB >> 6829571

Comparison of 4% chlorhexidine gluconate in a detergent base (Hibiclens) and povidone-iodine (Betadine) for the skin preparation of hemodialysis patients and personnel.

S E Goldblum, J A Ulrich, R S Goldman, W P Reed, P S Avasthi.   

Abstract

The abnormal cutaneous flora of hemodialysis (HD) patients might contribute to their frequent septic complications. We compared the effects of 13 wk of Betadine and 13 wk of Hibiclens on the skin flora of HD patients and personnel. Skin cultures were obtained weekly immediately prior to the disinfection, preceding each triweekly HD treatment, and monthly, at 2 and 4 hr postdisinfection. Total bacterial counts from predisinfection cultures were not significantly altered over either 13-wk treatment period. Hibiclens reduced total bacterial counts (p less than 0.01) and eradicated cutaneous staphylococci (p = 0.032) at both 2 and 4 hr postdisinfection significantly more than did Betadine. No reduction of staphylococcal sensitivity to either germicidal agent could be demonstrated. Neither agent was associated with severe adverse reactions and Hibiclens could not be detected in the blood. Hibiclens appears to offer short-term advantages over Betadine in the HD setting because of significantly longer duration of antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6829571     DOI: 10.1016/s0272-6386(83)80098-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

1.  Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.

Authors:  Julia Langgartner; Hans-Jörg Linde; Norbert Lehn; Michael Reng; Jürgen Schölmerich; Thomas Glück
Journal:  Intensive Care Med       Date:  2004-04-15       Impact factor: 17.440

2.  Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus.

Authors:  C E Haley; M Marling-Cason; J W Smith; J P Luby; P A Mackowiak
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.